Statistics for MacroGenics (id:8039 MGNX)

Valuation metrics

Market cap

224.07M

Enterprise value

57.80M

Trailing P/E (ttm)

25.32

Forward P/E

-1.48

PEG ratio

-1.48

Price/Sales (ttm)

1.59

Price/Book (mrq)

1.87

Enterprise Value/Revenue

0.41

Enterprise Value/EBITDA

-0.58

Overview

Shares outstanding

62.76M

Float

51.74M

Shares short

5.46M

% Held by insiders

0.03%

% Held by institutions

0.93%

Average volume (10 days)

913.47K

Average volume (90 days)

Price summary

52-Week low

2.95

52-Week high

21.88

52-Week change

-136.11%

Beta

2.08

50-Day moving average

3.67

200-Day moving average

8.29

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-69.07%

Operating margin

48.95%

Operational effectiveness

Return on assets

-22.15%

Return on equity

-62.17%

Income statement

Revenue (ttm)

2.26

Revenue per share (ttm)

2.26

Quarterly revenue growth (yoy)

2.21

Gross profit (ttm)

48.97M

EBITDA

-99,708,000.00

Net income to common (ttm)

-97,617,000.00

Diluted EPS (ttm)

-1.57

Quarterly earnings growth (yoy)

220.80%

Balance sheet

Total cash (mrq)

200.36M

Total cash per share (mrq)

3.19

Total debt (mrq)

34.10M

Total Debt/Equity (mrq)

28.40

Current ratio (mrq)

374.60%

Book value per share (mrq)

1.91

Cash flow

Cash flow statement

-58,003,000.00

Levered free cash flow (LFCF)

-21,178,250.00